News Sentiment

ANIP sentiment intelligence

ANI Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 82.07 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-4.6% over one week, +0.5% over four weeks, trend active, and near fair-value range.

Latest direct headline Negative

ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -4.6% Price reacting lower
Trend fit Trend active 0.5% over four weeks
Fair value 21.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 28
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 7
Stock Titan 5
Sahm 3
Investing.com 3
simplywall.st 3
Investing.com Canada 2
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 17
Regulatory and legal 1
Guidance 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47